Graves' orbitopathy post-SARS-CoV-2 vaccines: report on six patients.

J Abeillon-du PayratS GrunenwaldE GallM LadsousI RaingeardPhilippe J Caron

Published in: Journal of endocrinological investigation (2022)

In this study, we report the main data from six new patients with GO following SARS-CoV-2 vaccines. Clinicians need to be aware of the risk of new-onset or recurrent GO in predisposed patients with autoimmune thyroid diseases after COVID-19 vaccination. This study should not raise any concerns regarding SARS-CoV-2 vaccination since the risk of COVID-19 undoubtedly outweighs the incidence of uncommon GO after SARS-CoV-2 vaccination.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
end stage renal disease
chronic kidney disease
newly diagnosed
multiple sclerosis
risk factors
patient reported outcomes